Alpha Gold Fund Receives Recognition Of Excellence Awards
The Californer/10242355

Trending...
Areus Asset Management
MANHATTAN, N.Y. - Californer -- In its first month of eligibility, Areus Asset Management (Alpha Gold Fund) received two BarclayHedge - Recognition of Excellence Awards. Number #1 in the Currency Traders category, and Top 10 in the Short Term category for April 2023.

Earlier this year Alpha Gold also reached a significant milestone for any Portfolio Manager of twelve months of trading. In that period the portfolio returned to investors net +48.91%.

Designed as a technical, long-short, multi-strategy absolute returns-focused portfolio, the Alpha Gold Fund by Areus Asset Management focuses on the Spot Gold/USD currency pair.

An alternative approach:
Equities have underperformed in the past twelve months. However, unlike equities the Areus Alpha Gold Fund portfolio does not rely on asset price appreciation. Instead, it looks to generate returns from natural price action volatility, regardless of the general direction of the underlying asset price.

Spot the difference:
The fund primarily invests in XAUUSD spot gold to target high risk-adjusted returns uncorrelated to traditional asset classes. XAUUSD is the second most liquid pair in the currency market; the price of gold relative to the US dollar determines its value.

More on The Californer
Best in class:
The portfolio's returns come from realized trading gains in liquid spot gold transactions. High trading volume, tight spreads, and high liquidity make spot gold an evergreen asset class. Using algorithms to minimize human error, Alpha Gold executes a systematic, risk-disciplined approach to optimize speed and scale. Multiple trading strategies exploit various market opportunities and inefficiencies and diversify exposure to regulate overall capital drawdown.

Underpinning Areus Asset Management is an awarding-winning team who have received a total of fourteen, top 10 awards by BarclayHedge including world number #1 in the currency traders, systematic traders, CTA's and short-term categories.

2022 Returns: Alpha Gold vs Major Indexes*
Alpha Gold +48.91%
Dow Jones    -3.66%
Nasdaq        -12.07%
S&P 500        -8.81%

From the Portfolio Manager - April 2023 Update:
"The Areus Alpha Gold Fund performed steadily (+4.52%) in April, benefiting from long positions in spot gold. The rally in gold prices can be attributed to the bank run crisis and US credit crunch, as well as concerns of a ripple effect across the financial system. The instability in several financial institutions prompted investors to seek safety in gold, driving up demand and heightened the appeal for gold as a tangible asset independent of traditional banking structures. Rising inflationary pressures further contributed to the surge in gold prices as, as investors sought to safeguard their wealth".

More on The Californer
The fund facts:
The Areus Alpha Gold Fund is open only to US Accredited Investors, as defined by Rule 501 of Regulation D in the Securities Act, or Qualified Purchasers, as defined by the Investment Company Act of 1940, as amended; and Australian Wholesale Investors under S.708 of the Corporations Act 2001. Prospective Investors will be asked to provide either supporting documents or third-party verification of such status, certify that they are eligible to invest, and must acknowledge that they have received and read all investment materials. *Referenced Alpha compounding returns are that of the underlying portfolio manager's (USD) investment fund portfolio since its March 1st, 2022, inception and have been calculated net of the fees outlined in the Investment Information Memorandum. *Past performance is not indicative of future performance. Please visit www.areusasset.management to read the full Disclaimer and the Investment Information Memorandum for all information relating to the Areus Alpha Gold Fund.

Contact
Areus Asset Management
***@areusasset.management


Source: Areus Asset Management
Filed Under: Investment, Financial

Show All News | Report Violation

0 Comments

Latest on The Californer